Reference number : GC-2017-Q2-00348, amendment number : , agreement type : G, recipient legal name : Kadem, Lyes (Concordia University)|Kadem, Lyes (Université Concordia), recipient country : CA, recipient province : nan, recipient city : Quebec|Québec, recipient postal code : nan, program name english : Idea to Innovation, program name french : De l'idée à l'innovation, program purpose english : Cardiovascular disease is the first cause of death in Canada, in the United States and most occidental countries._x000D_
Accurate diagnosis and treatment require high performance medical devices and continuous high-quality_x000D_
medical training. This is becoming hardly achievable using the "standard" medical education model._x000D_
Significant changes have been recently affecting the world of medicine: 1) an important reduction in physician_x000D_
teaching time; 2) a lower availability of patients as educational resources, 3) more strict medicolegal systems;_x000D_
4) accreditation and regulatory bodies putting more emphasis on continuous maintenance of competence. As a_x000D_
consequence, relying on real patients is becoming a less desirable option for resident training and maintenance_x000D_
of physician competence, leading to a significant increase in the demand for high-fidelity simulators. From_x000D_
another side, newly developed implantable medical devices are required to undergo an extensive series of_x000D_
bench testing. This includes not only performance testing of the device itself but also of its delivery system._x000D_
Currently existing cardiac simulators are, however, not optimized for advanced medical training and for_x000D_
close-to-real bench testing of medical devices. We have developed the first realistic complete heart simulator_x000D_
capable of reproducing normal and pathological conditions. The simulator is capable of reproducing normal_x000D_
and abnormal physiological pressure and flow conditions in anatomically correct heart cavities, providing a_x000D_
more realistic picture of the complex environment that will be experienced by the implantable medical device_x000D_
and by the medical trainee during the implantation procedure. The most important markets for our technology_x000D_
are the growing markets for medical simulators and for implantable cardiovascular medical devices. The_x000D_
objective of this market assessment grant application is to define and size the most suitable market for our_x000D_
technology before re-submitting our unsuccessful I2I phase I application, program purpose french : Cardiovascular disease is the first cause of death in Canada, in the United States and most occidental countries._x000D_
Accurate diagnosis and treatment require high performance medical devices and continuous high-quality_x000D_
medical training. This is becoming hardly achievable using the "standard" medical education model._x000D_
Significant changes have been recently affecting the world of medicine: 1) an important reduction in physician_x000D_
teaching time; 2) a lower availability of patients as educational resources, 3) more strict medicolegal systems;_x000D_
4) accreditation and regulatory bodies putting more emphasis on continuous maintenance of competence. As a_x000D_
consequence, relying on real patients is becoming a less desirable option for resident training and maintenance_x000D_
of physician competence, leading to a significant increase in the demand for high-fidelity simulators. From_x000D_
another side, newly developed implantable medical devices are required to undergo an extensive series of_x000D_
bench testing. This includes not only performance testing of the device itself but also of its delivery system._x000D_
Currently existing cardiac simulators are, however, not optimized for advanced medical training and for_x000D_
close-to-real bench testing of medical devices. We have developed the first realistic complete heart simulator_x000D_
capable of reproducing normal and pathological conditions. The simulator is capable of reproducing normal_x000D_
and abnormal physiological pressure and flow conditions in anatomically correct heart cavities, providing a_x000D_
more realistic picture of the complex environment that will be experienced by the implantable medical device_x000D_
and by the medical trainee during the implantation procedure. The most important markets for our technology_x000D_
are the growing markets for medical simulators and for implantable cardiovascular medical devices. The_x000D_
objective of this market assessment grant application is to define and size the most suitable market for our_x000D_
technology before re-submitting our unsuccessful I2I phase I application, agreement title english : An engineered 3D-printed realistic patient simulator: market assessment, agreement title french : An engineered 3D-printed realistic patient simulator: market assessment, agreement number : I2IPJ, agreement value : 14977.0, agreement start date : 2017-08-23, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada